- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02856022
A Comparison of Electrical Ilioinguinal Nerve Stimulation With Intravesical Irrigation for Bladder Pain Syndrome
A Comparison of the Efficacy of Electrical Ilioinguinal Nerve Stimulation and Intravesical Irrigation in Treating Patients With Bladder Pain Syndrome in Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Shanghai, China, 200030
- Shanghai Research Institute of Acupuncture and Meridian
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Diagnostic Criteria:
- Complaint of suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and night-time frequency, in the absence of proven urinary infection or other obvious pathology.
- Negative in urine routine test or urine cultivation.
- Urinating at least 7 times per day or having some urgency or pain (measured on linear analog scales)
Inclusion Criteria:
- Providing informed consent to participate in the study;
- Willing to undergo a cystoscopy under general or regional anesthesia when indicated during the course of the study;
- Female patients meeting the diagnostic criteria;
- Age ≥18 years and ≤80 years.
- Disease course ≥ 6 months
Exclusion Criteria:
- Bladder capacity of greater than 350 mL on awake cystometry;
- Absence of an intense urge to void with the bladder is filled to 150 mL of liquid filling medium;
- The demonstration of phasic involuntary bladder contractions on cystometry using the fill rate just described;
- Duration of symptoms less than 9 months;
- Absence of nocturia;
- Symptoms relieved by antimicrobial agents, urinary antiseptic agents, anticholinergic agents, or antispasmodic agents;
- A frequency of urination while awake of less than 8 times per day;
- A diagnosis of bacterial cystitis or prostatitis within a 3-month period;
- Bladder or ureteral calculi;
- Active genital herpes;
- Uterine, cervical, vaginal, or urethral cancer;
- Urethral diverticulum;
- Cyclophosphamide or any type of chemical cystitis;
- Tuberculous cystitis;
- Radiation cystitis;
- Benign or malignant bladder tumors;
- Vaginitis;
- Age younger than 18 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Electrical ilioinguinal nerve stimulation
|
Four abdominal points are selected. The upper two points are located 2.5 cun bilateral to Guanyuan (Ren 4). The lower two points are located 1.5 cun bilateral to Zhongji (Ren 3). Four long needles are punctured obliquely 1~2 cun in depth (depending on the fat layer thickness of the patient) to the four points to make the needling sensation reaching the urethra or vulva. After the needling sensation reach the above regions, each of two pairs of electrodes from a device are connected with the two ipsilaterally inserted needles. The parameters are continuous waves, a frequency of 2.5 Hz and intensity that the patient feels comfortable for 60 min, three times a week for at least four weeks. |
|
Active Comparator: Intravesical Irrigation
|
The patient was asked to lie on a couch in a lithotomy position after urination.
A catheter was passed through the urethra into the bladder and any residual urine drained.
The Cystistat 50mL 40mg (sodium hyaluronate, Bioniche Teoranta, Ireland) solution is instilled through the catheter into the bladder.
The catheter is then withdrawn leaving the Cystistat inside the bladder coating the lining.
It was recommended the solution was retained for as long as possible, ideally at least 30 minutes.
The instillation is once weekly for at least four weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Bladder Pain/ Interstitial Cystitis Symptom Score (BPIC-SS)
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
SF-36 questionnaire
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
Investigators
- Study Director: Siyou Wang, M.D, Shanghai Research Institute of Acupuncture and Meridian
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZYY201606
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Painful Bladder Syndrome
-
University Of PerugiaUnknownPainful Bladder Syndrome (PBS)Italy
-
David SheynRecruitingInterstitial Cystitis | Painful Bladder Syndrome | Painful Bladder Syndrome (PBS)United States
-
Case Western Reserve UniversityNot yet recruitingInterstitial Cystitis | Painful Bladder Syndrome (PBS)
-
Ain Shams UniversityCompletedInterstitial Cystitis | Painful Bladder Syndrome (PBS)Egypt
-
University of Alabama at BirminghamWashington University Early Recognition CenterCompleted
-
Rambam Health Care CampusUnknownPainful Bladder SyndromeIsrael
-
Watson PharmaceuticalsCompletedInterstitial Cystitis | Painful Bladder SyndromeUnited States
-
IRCCS Policlinico S. MatteoCompletedInterstitial Cystitis | Painful Bladder SyndromeItaly
-
Mundipharma Research GmbH & Co KGCompletedPain | Interstitial Cystitis | Painful Bladder SyndromePoland, Germany, Hungary, Czechia, United Kingdom
-
PfizerCompletedInterstitial Cystitis | Painful Bladder SyndromeCanada, United States, France, Denmark, Finland, Germany
Clinical Trials on Electrical ilioinguinal nerve stimulation
-
Karolinska University HospitalActive, not recruitingHip Fractures | Orthopedic Disorder | Post Operative Pain | Arthroplasty, Replacement, Hip | Internal FixationSweden
-
University of MichiganThe Craig H. Neilsen Foundation; International Society for the Study of Women...CompletedSpinal Cord Injuries | Female Sexual DysfunctionUnited States
-
University of Colorado, BoulderUniversity of Colorado, Denver; Colorado State UniversityWithdrawn
-
ADIR AssociationCompletedChronic Obstructive Pulmonary DiseaseFrance
-
University of L'AquilaCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedTendinopathy | Cervical Radiculopathy | Post-herpetic Neuralgia | Chronic Back Pain | Limbs Arthrosis | Non Arthrosic Limbs Arthralgia | Chronic Lomboradiculalgia | Post-surgical Peripheral Neuropathic Pain | Post Trauma Neuropathic Pain | Complex Regional Pain Syndrome Type I or IIFrance
-
César Fernández-de-las-PeñasCompleted
-
Université de SherbrookeCompleted
-
Institut Cancerologie de l'OuestTerminated
-
Shanghai Institute of Acupuncture, Moxibustion...RenJi HospitalCompletedLower Urinary Tract Symptoms | Spinal Cord Injuries | Incontinence | DysuriaChina